glp 1 and kidney GLP-1 receptor agonists are increasingly used to treat type 2 diabetes obesity, and trials have shown reductions in cardiovascular risk and slowing of failure. Adverse events are mostly gastrointestinal Role of GLP-1 Agonists &
Description
In this study, the researchers conducted one of the first randomized controlled trials of semaglutide for people with alcohol use disorder, examining the effects of this medication on alcohol craving and consumption in a non-treatment-seeking sample

During this period, there was a significant decrease in 24-hour urine oxalate (4016 to 3211 mg/d, P = 0.002), sulfate (2110 to 179 mmol/d, P = 0005), and ammonium (3522 to 2915 mEq/d, P = 0.01) excretion rates

By addressing these three areas, semaglutide provides a powerful tool for weight management, particularly for those who have struggled with traditional diet and exercise alone

Those are GLP-1 weight loss medications

If you have been on semaglutide for several weeks and are not seeing expected results, check your dosing accuracy first

a focal point for well-known local favorites and minority-owned start-ups from chefs and owners shut out of traditional restaurant ownership
